More stories

Pα+ Psychedelic Patent Analysis: A Mebufotenin Melee (Dec ’23 & Jan ’24)

In our latest Psychedelic Patent Analysis, we take a deep dive into recent patent-related developments at two companies that are both pursuing 5-MeO-DMT for...

PT488 – The Cost of War: Veterans’ Mental Health and Government Responsibility

In this episode, Joe interviews Matthew ‘Whiz’ Buckley: former decorated US Navy F/A-18 Hornet fighter pilot and now, founder and CEO of No Fallen...

Pα+ Psychedelic Bulletin #156: Canada’s First Published Psilocybin Trial; University of Maryland Joins Terran’s...

Featured content in this Issue: This is the first issue of our Psychedelic Bulletin that’s exclusively for Pα+ subscribers. Head to our Join page...

PT487 – Interoception, Healing Through Connection, and Learning to Trust Our Bodies

In this episode, David interviews Saga Briggs: freelance journalist and author of How to Change Your Body: The Science of Interoception and Healing Through...

Pα+: Day 2 Dispatch from ‘Advancing Psychedelic Clinical Study Design’, Hosted by the Reagan-Udall...

On January 31st and February 1st, the Reagan-Udall Foundation for the Food and Drug Administration hosted a two-day virtual meeting, Advancing Psychedelic Clinical Study...

Opinion: How Ayahuasca Could Change You

With ayahuasca being cast into the spotlight, curious minds from all over the world are heading to Central and South America to experience it...

Natural Medicine Advisory Bulletin #8.1: Recommendation Round-up

Written by Jeff Fitzgerald and Vicente LLP as part of our Colorado Natural Medicine Health Act Tracker. In January of 2024, following over 75...

Natural Medicine Advisory Bulletin #8: January 2024

Written by Jeff Fitzgerald and Vicente LLP as part of our Colorado Natural Medicine Health Act Tracker. On January 19th, 2024, Colorado’s Natural Medicine...

Pα+: Dispatch from ‘Advancing Psychedelic Clinical Study Design’, Hosted by the Reagan-Udall Foundation for...

On January 31st and February 1st, the Reagan-Udall Foundation for the Food and Drug Administration 1 hosted a virtual event, Advancing Psychedelic Clinical Study...

PT486 – 5-MeO-DMT, Somatic Release, and Creating Context for Spirituality

In this episode, Joe interviews Steve Rio: psychedelic guide, performance and transformation coach, musician, and co-founder of Enfold, a retreat center in BC, Canada....

Psychedelic Research Bulletin: January 2024

This January we were treated to a mix of novel psychedelic trials and an unusually large amount of re-analyses of earlier studies. Ibogaine was...

PT485 – Meeting People Where They Are: Why the Underground Will Always Thrive

In this episode, Joe interviews Ayize Jama-Everett: author; educator; filmmaker; and therapist with a long history of work in substance use and mental health...

Most popular